Crinetics Pharmaceuticals (CRNX) has shared an update.
Crinetics Pharmaceuticals, Inc. is set to present five abstracts from its clinical development program at the prestigious ENDO 2024, the Endocrine Society’s annual meeting. This event is scheduled for June 1-4 in Boston, Massachusetts, and the announcement has been made public through a press release, indicating a significant milestone for the company in showcasing its research progress to industry professionals and potential investors.
For a thorough assessment of CRNX stock, go to TipRanks’ Stock Analysis page.
